Martin H. Floch, MD, in an editorial titled “Fecal Bacteriotherapy, Fecal Transplant, and the Microbiome” (2010) advocates that fecal transplantation therapy has seen sufficient medical evidence, and has been around for long enough to be a commonly accepted medical therapy despite some remaining skeptics. Floch supports this statement using three previously published studies that reveal significant benefits as a result of fecal transplantation. The purpose of this editorial is to advocate for FTT as a therapy in order to increase the prevalence of it’s use in medical practice. Floch’s intended audience is healthcare professionals, who he establishes a scholarly relationship with by displaying primary research as evidence.
